SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in ...
SOUTH SAN FRANCISCO - Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical-stage biopharmaceutical company with a market capitalization of $53 million, has appointed Ramón Polo as Senior Vice President ...
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., a U.S. subsidiary of Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback